Publications of T. Kümpfel
All genres
Journal Article (17)
1.
Journal Article
49 (9), pp. 558 - 562 (2012)
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. Journal of Medical Genetics 2.
Journal Article
258 (9), pp. 1665 - 1669 (2011)
De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology 3.
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 4.
Journal Article
13 (9), pp. 1138 - 1145 (2007)
Time of interferon- β 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients. Multiple Sclerosis 5.
Journal Article
66 (2), pp. 295 - 303 (2007)
Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clinical Endocrinology 6.
Journal Article
6 (19), doi:10.1186/1471-2377-6-19 (2006)
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurology 7.
Journal Article
12 (7), pp. 432 - 437 (2006)
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism & Related Disorders 8.
Journal Article
62 (2), pp. 277 - 280 (2005)
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Archives of Neurology 9.
Journal Article
86, pp. 1610 - 1615 (2001)
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism 10.
Journal Article
47, pp. 276 - 277 (2000)
Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Annals of Neurology 11.
Journal Article
102, pp. 337 - 339 (2000)
Non-convulsive status epilepticus with marked neuropsychiatric manifestations and MRI changes after treatment of hypercalcaemia. Acta Neurologica Scandinavica 12.
Journal Article
55, pp. 1231 - 1233 (2000)
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS. Neurology 13.
Journal Article
157 (2000)
Paroxetine for depersonalization associated with multiple sclerosis. American Journal of Psychiatry 14.
Journal Article
70, pp. 431 - 438 (1999)
Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 15.
Journal Article
53, pp. 772 - 777 (1999)
Dysregulation of the hypothalamic-pituitary-adrenal axis is related to the clinical course of multiple sclerosis. Neurology 16.
Journal Article
69, pp. 1111 - 1114 (1998)
Exazerbation von Tics durch Prednisolon. Nervenarzt 17.
Journal Article
66, pp. 326 - 330 (1998)
Prolongierter nichtkonvulsiver Status epilepticus als klinische Erstmanifestation einer Epilepsie im Rahmen einer HIV-Infektion.: Fallbericht mit EEG- und MRT-Verlauf. Fortschritte der Neurologie/Psychiatrie Thesis - PhD (1)
18.
Thesis - PhD
Einfluß der Neuropeptide Substanz P und Calcitonin Gene-Related Peptide auf die zerebrale Mikrozirkulation in der Frühphase der experimentellen Pneumokokkenmeningitis. Dissertation, Ludwig-Maximilians-Universität, München (1997)